{"tid":184555,"cid":15,"subCid":0,"title":"【股東減持】李氏大藥廠遭股東折讓一成減持 套約5.8億元","createTime":"2017-04-03T01:23:53.000Z","updateTime":"2017-04-03T01:23:53.000Z","uid":17738,"like":0,"dislike":0,"uniUserReply":0,"replies":[{"pid":"7b887e92d883edf7664c61b958c570966ea06370","tid":184555,"uid":17738,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2017-04-03T01:23:53.000Z","msg":"<img src=\"https://img.eservice-hk.net/upload/2017/04/03/092312_7132b60e1843149d782e5118cdb40059.jpg\" data-thumbnail-src=\"https://i.lih.kg/thumbnail?u=https%3A%2F%2Fimg.eservice-hk.net%2Fupload%2F2017%2F04%2F03%2F092312_7132b60e1843149d782e5118cdb40059.jpg&h=feeabbe6&s={SIZE}\" /><br />\n<br />\n李氏大藥廠（950）公布，被主要股東Essetifin S.p.A.減持合共約8523萬股，每股作價6.8元，較上日收市價折讓9.33%，套現近5.8億元，三位承配人分別為執行董李小羿；另一位公司現有主要股東以及一位獨立第三方，分別獲配售3933.93萬股（6.66%）、1700萬股（2.88%）以及2889.2萬股（4.9%）。<br />\n<br />\n完成後，Essetifin S. p. A 於公司持股量，將由24.07%降到9.63%。<br />\n<br />\n<a href=\"http://hkm.appledaily.com/detail.php?guid=56515403&amp;category_guid=7015342&amp;category=instant&amp;issue=20170403\" data-sr-url=\"https://r.lihkg.com/link?u=http%3A%2F%2Fhkm.appledaily.com%2Fdetail.php%3Fguid%3D56515403%26category_guid%3D7015342%26category%3Dinstant%26issue%3D20170403&d=FyFnEhDp3tEmtF3AT420RuI2ZYfPb188nwqbwuz8hpE%3D&h=8847cd2f\" data-ef-url=\"https://embed.lih.kg/frame?u=http%3A%2F%2Fhkm.appledaily.com%2Fdetail.php%3Fguid%3D56515403%26category_guid%3D7015342%26category%3Dinstant%26issue%3D20170403&h=a7676bff\" target=\"_blank\">http://hkm.appledaily.com/detail.php?guid=56515403&amp;category_guid=7015342&amp;category=instant&amp;issue=20170403</a>"}]}